TuHURA Biosciences (HURA) Change in Cash (2010 - 2026)
TuHURA Biosciences (HURA) posted quarterly Change in Cash of $2.7 million for Q1 2026, up 141.6% year-over-year from $1.1 million in Q1 2025, and up 190.31% quarter-over-quarter from $922533.0 in Q4 2025.
TuHURA Biosciences (HURA) Change in Cash (2010 - 2026) Analysis & Trends
TuHURA Biosciences' Change in Cash history runs 17 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- In Q1 2026, Change in Cash rose 141.6% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $78296.0 (down 99.66% YoY), while the FY2025 annual figure was -$9.0 million, down 200.5% from the prior year.
- Change in Cash for Q1 2026 stood at $2.7 million, up from $922533.0 in the prior quarter.
- The five-year high for Change in Cash was $15.9 million in Q3 2024, with the low at -$8.5 million in Q2 2023.
- The 5-year median for Change in Cash is -$1.3 million (2023), against an average of -$336320.5.
- The sharpest annual moves came in 2022 and 2024: Change in Cash tumbled 262.85% in 2022, then surged 1307.81% in 2024.
- TuHURA Biosciences' Change in Cash stood at -$5.6 million in 2022, then jumped by 84.3% to -$877000.0 in 2023, then jumped by 1916.53% to $15.9 million in 2024, then slumped by 94.21% to $922533.0 in 2025, then jumped by 190.31% to $2.7 million in 2026.
- Business Quant data shows HURA's Change in Cash at $2.7 million in Q1 2026, $922533.0 in Q4 2025, and -$5.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - | -5.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.68 Mn |
| Dec 31, 2025 | 922,533.00 |
| Sep 30, 2025 | -5.82 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | -6.44 Mn |
| Sep 30, 2024 | 15.93 Mn |
| Jun 30, 2024 | 8.65 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Dec 31, 2023 | -877,000.00 |
| Sep 30, 2023 | -1.32 Mn |
| Jun 30, 2023 | -8.55 Mn |
| Mar 31, 2023 | -1.83 Mn |
| Dec 31, 2022 | -5.59 Mn |
| Sep 30, 2022 | -4.70 Mn |
| Mar 31, 2022 | -5.23 Mn |
| Dec 31, 2021 | -5.28 Mn |
| Sep 30, 2021 | 8.80 Mn |
| Jun 30, 2021 | -5.18 Mn |
| Mar 31, 2021 | -1.44 Mn |
| Dec 31, 2020 | -5.44 Mn |